| Cavia porcellus |
Cavia porcellus |
Decrease in blood glucose |
70.0 |
% |
10.1021/jm00148a011 |
| Cavia porcellus |
Cavia porcellus |
MED |
7.5 |
mg |
10.1016/j.ejmech.2021.113726 |
| Cavia porcellus |
Cavia porcellus |
Reduction |
46.0 |
% |
10.1021/jm00144a031 |
| Cavia porcellus |
Cavia porcellus |
Reduction |
46.0 |
% |
10.1021/jm00346a006 |
| Cercopithecidae |
Monkey |
Reduction |
50.0 |
% |
10.1021/jm00346a006 |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
6711.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
15000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-3 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Bile salt export pump |
IC50 |
135000.0 |
nM |
10.1093/toxsci/kfq269 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Bradykinin B1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bradykinin B2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
Activity |
88.0 |
% |
10.1021/jm7015683 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 1 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Canalicular multispecific organic anion transporter 2 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Carbonic anhydrase I |
Ki |
50000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Homo sapiens |
Carbonic anhydrase II |
Ki |
50000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Homo sapiens |
Carbonic anhydrase IX |
Ki |
50000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Homo sapiens |
Carbonic anhydrase XII |
Ki |
50000.0 |
nM |
10.1016/j.ejmech.2016.10.037 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cholecystokinin B receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Corticotropin releasing factor receptor 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
IC50 |
27000.0 |
nM |
10.1021/jm0209578 |
| Homo sapiens |
Cytochrome P450 2D6 |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dihydrofolate reductase |
Ki |
140000.0 |
nM |
10.1021/acs.jmedchem.0c00546 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
25200.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endothelin receptor ET-B |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor beta |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Gastric inhibitory polypeptide receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HCT-116 |
Activity |
nan |
None |
10.1016/j.ejmech.2016.10.037 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-9.26 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
3.23 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Hypoxia-inducible factor 1 alpha |
Potency |
6309.6 |
nM |
None |
| Homo sapiens |
Kappa opioid receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Melanocortin receptor 4 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
IC50 |
133000.0 |
nM |
10.1093/toxsci/kft176 |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuropeptide Y receptor type 2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neurotensin receptor 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
18335.2 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
38570.8 |
nM |
None |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
21999.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Prelamin-A/C |
Potency |
398.1 |
nM |
None |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
8904.9 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Drug uptake |
570.0 |
pmol/mg |
10.1021/jm400966v |
| Homo sapiens |
Solute carrier family 22 member 1 |
FC |
39.0 |
None |
10.1021/jm400966v |
| Homo sapiens |
Solute carrier family 22 member 1 |
IC50 |
10000.0 |
nM |
10.1023/a:1019870831174 |
| Homo sapiens |
Solute carrier family 22 member 2 |
Drug uptake |
450.0 |
pmol/mg |
10.1021/jm400966v |
| Homo sapiens |
Solute carrier family 22 member 2 |
FC |
35.0 |
None |
10.1021/jm400966v |
| Homo sapiens |
Solute carrier family 22 member 2 |
IC50 |
65000.0 |
nM |
10.1023/a:1019870831174 |
| Homo sapiens |
Solute carrier family 22 member 3 |
Ratio |
32.2 |
None |
10.1021/acs.jmedchem.2c01075 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
34.5 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
-2.3 |
% |
10.1021/jm300212s |
| Homo sapiens |
Solute carrier organic anion transporter family member 2B1 |
Inhibition |
16.7 |
% |
10.1021/jm300212s |
| Homo sapiens |
Thromboxane A2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
UMUC3 |
IC50 |
250000.0 |
nM |
10.1021/acs.jmedchem.2c01244 |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Vasopressin V2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Mus musculus |
Mus musculus |
Activity |
-3.4 |
% |
10.1021/jm8011933 |
| Mus musculus |
Mus musculus |
Activity |
-0.14 |
% |
10.1021/jm8011933 |
| Mus musculus |
Mus musculus |
Activity |
106.0 |
% |
10.1021/jm8011933 |
| Mus musculus |
Mus musculus |
Activity |
nan |
None |
10.1021/jm8011933 |
| Mus musculus |
Mus musculus |
Inhibition |
21.0 |
% |
10.1021/jm00189a022 |
| Mus musculus |
Mus musculus |
LD50 |
160.0 |
mg.kg-1 |
10.1021/jm00144a031 |
| Mus musculus |
Mus musculus |
LD50 |
900.0 |
mg.kg-1 |
10.1021/jm00144a031 |
| Nakaseomyces glabratus |
Nakaseomyces glabratus |
FICI |
0.5 |
None |
10.1016/j.ejmech.2021.113293 |
| Plasmodium falciparum |
Plasmodium falciparum |
IC50 |
0.0 |
nM |
10.1016/j.bmc.2010.01.068 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
8087.5 |
nM |
None |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cytochrome P450 2D1 |
Inhibition |
nan |
% |
10.1021/jm0209578 |
| Rattus norvegicus |
Cytochrome P450 2D18 |
IC50 |
833000.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
Cytochrome P450 2D2 |
IC50 |
45400.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
Cytochrome P450 2D3 |
IC50 |
1927000.0 |
nM |
10.1021/jm0209578 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Glutamate (NMDA) receptor subunit zeta 1 |
AC50 |
2321.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Peripheral myelin protein 22 |
Potency |
13789.4 |
nM |
None |
| Rattus norvegicus |
Rattus norvegicus |
Blood glucose |
5.52 |
mM l-1 |
10.1021/jm00361a007 |
| Rattus norvegicus |
Rattus norvegicus |
Blood lactate |
12.2 |
mg dl-1 |
10.1021/jm00167a022 |
| Rattus norvegicus |
Rattus norvegicus |
Change |
-10.0 |
% |
10.1021/jm00361a007 |
| Rattus norvegicus |
Rattus norvegicus |
Change |
-6.0 |
% |
10.1021/jm00361a007 |
| Rattus norvegicus |
Rattus norvegicus |
ED20 |
0.16 |
mM kg-1 |
10.1021/jm00361a006 |
| Rattus norvegicus |
Rattus norvegicus |
ED20 |
1.0 |
mM kg-1 |
10.1021/jm00361a006 |
| Rattus norvegicus |
Rattus norvegicus |
ED50 |
1000.0 |
umol.kg-1 |
10.1021/jm00361a006 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
21.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
26.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
31.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
35.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
58.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
61.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
63.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
68.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
70.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
84.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
98.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
101.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Glucose rise |
129.0 |
mg dl-1 |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
IC50 |
180000.0 |
nM |
10.1021/jm00361a007 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
0.0 |
% |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
57.0 |
% |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
64.0 |
% |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
71.0 |
% |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
Inhibition |
81.0 |
% |
10.1021/jm00129a015 |
| Rattus norvegicus |
Rattus norvegicus |
LD50 |
160.0 |
mg.kg-1 |
10.1021/jm00346a006 |
| Rattus norvegicus |
Rattus norvegicus |
LD50 |
900.0 |
mg.kg-1 |
10.1021/jm00346a006 |
| Rattus norvegicus |
Rattus norvegicus |
Plasma glucose level |
85.0 |
mg dl-1 |
10.1021/jm00167a022 |
| Rattus norvegicus |
Rattus norvegicus |
Plasma Insulin |
86.1 |
pM l-1 |
10.1021/jm00361a007 |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
0.0 |
% |
10.1021/jm00144a031 |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
0.0 |
% |
10.1021/jm00346a006 |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
25.3 |
% |
10.1021/jm00144a031 |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
52.9 |
% |
10.1021/jm00144a031 |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
62.0 |
% |
10.1021/jm00144a031 |
| Rattus norvegicus |
Rattus norvegicus |
Reduction |
62.0 |
% |
10.1021/jm00346a006 |
| Rattus norvegicus |
Solute carrier family 22 member 1 |
Km |
15600.0 |
nM |
10.1124/jpet.102.034140 |
| Rattus norvegicus |
Voltage-gated L-type calcium channel alpha-1C subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Voltage-gated N-type calcium channel alpha-1B subunit |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| None |
ADMET |
Activity |
nan |
None |
10.1021/jm8011933 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (acute) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (animal toxicity known) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (benign tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (granulomatous hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (mechanism) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
% |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (moderate) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Hepatotoxicity (time to onset) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
NON-PROTEIN TARGET |
Potency |
14950.2 |
nM |
None |
| None |
NON-PROTEIN TARGET |
Potency |
21117.7 |
nM |
None |
| None |
Unchecked |
Hepatotoxicity (acute) |
1.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (association with vascular disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (choleostasis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (chronic liver disease) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cirrhosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (comment) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (cytolytic) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (malignant tumour) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (severe hepatitis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (steatosis) |
0.0 |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
Hepatotoxicity (successful reintroduction) |
nan |
None |
10.1016/s0399-8320(04)95062-2 |
| None |
Unchecked |
IC50 |
3800.0 |
nM |
10.1021/acs.jmedchem.1c01509 |
| None |
Unchecked |
IC50 |
170000.0 |
nM |
10.1021/acs.jmedchem.0c00546 |
| None |
Unchecked |
IC50 |
570000.0 |
nM |
10.1021/acs.jmedchem.2c01244 |